Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.2%

1 terminated/withdrawn out of 24 trials

Success Rate

93.3%

+6.8% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

0%

0 of 14 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
7(50.0%)
Phase 2
6(42.9%)
Phase 3
1(7.1%)
14Total
N/A(7)
Phase 2(6)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT07419373Phase 2Recruiting

ARN-75039 Lassa Fever Treatment in West Africa

Role: collaborator

NCT06387511Not ApplicableCompleted

Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months

Role: lead

NCT06212336Phase 2Recruiting

ISTH/ANRS 0409s INTEGRATE Lassa Fever Study

Role: collaborator

NCT06841614Phase 3Not Yet Recruiting

EBOla Post-Exposure Prophylaxis

Role: collaborator

NCT05202288Phase 2Not Yet Recruiting

Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Role: collaborator

NCT06136117Completed

Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts

Role: collaborator

NCT06840860Recruiting

Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)

Role: collaborator

NCT06613867Completed

Wakobo-ti-Kodro: Improving Identification of Pregnancy at Risk of Obstetric Complications at Community Level

Role: lead

NCT03655561Active Not Recruiting

Lassa Fever Clinical Course and Prognostic Factors in Nigeria

Role: lead

NCT03751475Not ApplicableCompleted

Optimizing Acute Malnutrition Management in Children Aged 6 to 59 Months in Democratic Republic of Congo

Role: lead

NCT05409300Phase 2Active Not Recruiting

Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

Role: collaborator

NCT06123390Not ApplicableUnknown

Evaluating RISQ System Implementation in Acutely Malnourished Children in Chad (CRIMSON)

Role: collaborator

NCT04907682Phase 2Completed

Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever

Role: collaborator

NCT04920838Phase 2Unknown

Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection

Role: collaborator

NCT04698070Not ApplicableCompleted

Optimizing Acute Malnutrition Management in Children Aged 6 to 59 Months in Niger (OptIMA Niger)

Role: lead

NCT04885543Completed

COVID-19 STAndard of Care in Sub-Saharan Africa

Role: lead

NCT04815174Completed

Observational Study of the Clinico-biological Evolution and Standard of Care Offered to Patients With Ebola Virus Disease

Role: lead

NCT04582773Completed

Improving the Outcomes of Community-based Management of Acute Malnutrition

Role: collaborator

NCT04250168Terminated

Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response

Role: collaborator

NCT03027505Not ApplicableCompleted

Integrated Treatment Protocol for Acute Malnutrition: A Non Inferiority Trial in Burkina Faso

Role: lead